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The limited availability of cadaveric human donor pancreata as well as the incomplete success of the Edmonton protocol for
humanisletallograftsfastensearchfornewsourcesofinsulintheproducingcellsforsubstitutioncelltherapyofinsulin-dependent
diabetes mellitus (T1DM). Starting from isolated neonatal porcine pancreatic islets (NPIs), we have obtained cell monolayers that
were exposed to microencapsulated monolayered Sertoli cells (ESCs) for diﬀerent time periods (7, 14, 21 days). To assess the
development of the cocultured cell monolayers, we have studied either endocrine cell phenotype diﬀerentiation markers or c-
kit, a hematopoietic stem cell marker, has recently been involved with growth and diﬀerentiation of β-cell subpopulations in
human as well as rodent animal models. ESC which were found to either accelerate maturation and diﬀerentiation of the NPIs
β-cell phenotype or identify an islet cell subpopulation that was marked positively for c-kit. The insulin/c-kit positive cells might
represent a new, still unknown functionally immature β-cell like element in the porcine pancreas. Acceleration of maturation and
diﬀerentiation of our NPI cell monolayers might generate a potential new opportunity to develop insulin-producing cells that may
suite experimental trials for cell therapy of T1DM.
1.Introduction
Correction of hyperglycemia by exogenous insulin may
delay or attenuate, but never eliminate, the risk for devel-
oping secondary complications during the time course of
T1DM [1]. Moreover, recently possible risks for malignan-
cies in diabetic patients treated with long-lasting insulin
analogues have been reported [2]. Transplantation (TX)
of insulin-producing tissue, whether being comprised of
whole pancreas or isolated islet cells, might fully restore
normoglycemia, thus obviating the need for daily exogenous
insulin supplementation. Moreover, the improved stability
of metabolic control, as achieved by islet TX, could restrain
both the onset and severity of the disease-related chronic
complications. Nevertheless, human islet allografts in totally
immunosuppressed patients with T1DM have been proven
quite limited, in terms of successful outcome [3]. The
majority of long-term transplanted islets failed to become
fully functional and sustain the transiently restored eug-
lycemia [3]. In addition, availability of human donor islets
usually is very restricted due to low organ donation rate
which does warrant looking for alternative cell sources like
neonatal porcine islets (NPIs), as human tissue substitutes
[4–7].2 Stem Cells International
In fact, meanwhile it is very diﬃcult to obtain and
culturemaintainadultporcineisletsbecauseoftheirintrinsic
fragility and short functional life-span, in contrast, NPIs
procurement is very easy, and above all, NPIs grow and
diﬀerentiate easier than adult porcine islets, have a long
functionallife-span,andareprotectedfromCD8+attack[8].
Currently, a major hurdle to use NPI for xenograft is the
delay in achieving the posttransplant normalization of blood
glucose in diabetic recipients. In fact, as reported by Korbutt
et al. [9] and Korbutt et al. [4], NPI may take 4–10 or more
weeks to reach as suﬃcient, diﬀerentiated β- c e l lm a s sa st o
enablereversalofhyperglycemiaafterTXindiabeticrodents.
This pre-TX time-lag poses two major problems: (a)
recipients need to be treated with exogenous insulin, until
the graft becomes functional; (b) the implanted islets are
exposed to environmental, as much as detrimental, chronic
hyperglycemia.
Several eﬀorts have been made to accelerate the lengthy
NPI maturation process, both in vivo and in vitro, but these
procedures unfortunately are associated with relevant cell
mass loss.
Freshly isolated NPI cell populations are typically com-
prised of a minority of β-cells, and a majority of cytokeratin-
7+ (Ck7, a ductal cell marker) cells. The remaining cells
coexpress either insulin, or epithelial cell markers [5]o r
pancreatic and duodenal homeobox gene-1 (PDX-1), which
regulates glucose-stimulated insulin gene expression [9]. In
this respect, we had previously shown that coincubation
of NPI with Sertoli cells (SCs) induced rapid and sig-
niﬁcant maturation and diﬀerentiation of NPI immature
into functionally competent, mature β-cells, by promoting
accelerationofthediﬀerentiation/developmentalprocess[5].
The assumption was that SC would provide nutrients
and immunomodulatory and trophic factors that were likely
to improve survival and development as well as functional
competence of NPI [5, 10]. To ameliorate SC eﬀects on
NPI, we have developed a culture procedure to obtain NPI
monolayers (maintained in vitro up to 90 days) treated with
high level glucose and glucagon-like peptide 1 (GLP-1) [11].
In order to ascertain mechanisms underlying SC-driven
acceleration of the NPI cell monolayer diﬀerentiation, we
incubated NPI with ESC for diﬀerent time periods (7, 14,
21 days). At the starting time, cell monolayer immunophe-
notype was similar to isolated primary NPI. To monitor
progress of the incubated cell diﬀerentiation, we have
examined either markers of endocrine cell phenotype diﬀer-
entiation or c-kit, a hematopoietic stem cell marker, which
has recently been involved with growth and diﬀerentiation
of β-cell subpopulations in humans as well as rodents. In
fact, tyrosine-kinase proteins are involved in growth and
diﬀerentiation of diﬀerent cell types. Among such proteins,
a typical hematopoietic stem cell marker [12–14], whose
ligand is stem cell factor (SCF) has progressively fueled hope
on its possible role in developmental biology of islet cells
[14]. Furthermore, c-kit in the form of RNA transcripts
has been found in a β-cell subpopulation, suggesting that
mature β-cells may derive from c-kit positive cells, within
cell regeneration and neogenesis pathways [15, 16]. Even if
c-kit has already been shown in rodents and also in humans
by Li et al. [17], our data are, to our knowledge, the ﬁrst
to be observed in pigs, a potential and promising xenogenic
cell source for cell therapy of T1DM, because of the limited
availability of cadaveric human donor pancreata.
In summary, the present paper describes the possible
mechanisms by which SC may induce rapid and signiﬁcant
maturation and diﬀerentiation of NPI cell monolayers into
functionally competent β-cells.
2.MaterialsandMethods
2.1. Isolation of Neonatal Porcine Islets. NPIs were isolated
according to previously established methods [3, 4]f r o m
Neonatal “Large White” pigs (birth time range: 1–3 days).
Brieﬂy, the piglets were anesthetized with 0.1mg/Kg azap-
eron (Stresnil, 40mg/mL, Janssen, Bruxelles, Belgium) and
15mg/Kg ketamine (Imalgene, 100mg/mL, Gellini Farma-
ceutici, Aprilia, Italy) coadministered intramuscularly. The
piglets underwent total laparotomy, by midline incision,
in order to carefully remove the pancreas. To prevent
bacterial contamination, particular care was taken to avoid
bowel nicking. Upon transportation to the laboratory in
Eurocollins (SALF, Bergamo, Italy) on ice, the pancreas was
cut into small pieces (1–3mm3) and washed in Hank’s
balanced salt solution (HBSS) (Sigma Chemical Co, St.
Louis, Mo, USA) according to previously reported methods.
The tissue was ﬁnely minced and thereafter shaken in a
collagenasesolution(collagenaseP,Roche,Milano,Italy)and
subsequently washed twice in HBSS (Sigma Chemical Co)
supplemented with 100U/mL penicillin +0.1mg/mL strep-
tomycin (Sigma Chemical Co). Finally, the tissue was resus-
pended in HAM-F12 (EuroClone, Wetherby, UK) supple-
mented with 0.5% bovine serum albumin, fraction V (BSA)
(Sigma Chemical Co), 50μM 3-isobutyl-1-methylxanthine
(IBMX) (Sigma Chemical Co), 10mM nicotinamide (Sigma
ChemicalCo),2mML-glutamine(SigmaChemicalCo),and
penicillin +0.1mg/mL streptomycin (Sigma Chemical Co)
a n dp l a t e di n1 0 0× 15mm Petri dishes (Becton Dickinson
Labware, Lincoln Park, NY, USA) (10000NPCC/plate).
2.2.CultureMaintenanceofNeonatalPorcineIsletMonolayers.
At day 4 of the isolation, NPI viability was assessed by
stainingthepreparationwithethidiumbromide(EB)(Sigma
Chemical Co) and ﬂuorescein-diacetate (FDA) (Sigma
Chemical Co), as previously described [18]. NPI were
than replated in Click’s medium (Sigma Chemical Co)
supplemented with 10% fetal bovine serum (EuroClone,
Wetherby, UK), 0.5% bovine serum albumin, fraction V
(BSA) (Sigma Chemical Co), 10mM nicotinamide (Sigma
ChemicalCo),2mML-glutamine(SigmaChemicalCo),and
penicillin +0.1mg/mL streptomycin (Sigma Chemical Co)
using T25 tissue ﬂasks for adherent cell growth (Greiner
Bio-one, Frickenhausen, Germany), at a concentration of
30NPI/ﬂask. Upon adhesion to ﬂask, NPI lost their normal
three-dimensional architecture and formed cell monolayers.
2.3. Isolation of Sertoli Cells. SCs were isolated from neonatal
prepubertal “Large-White” pigs, aging 7–10 days, accordingStem Cells International 3
to the previously established methods, slightly modiﬁed in
our laboratory [5, 19].
Brieﬂy, after anesthesia, the testes were removed and
ﬁnely minced prior to undergoing stepwise enzymatic
digestion: ﬁrst step with Collagenase P (Roche Diagnostics,
S.p.A., Monza, Italy) in HBSS (Sigma Chemical Co) to
dissociate the seminiferous tubules; second step with trypsin
+DNAse I in HBSS. The tissue digest, resuspended in
glycine to eliminate the residual Leydig and peritubular cells
[20], was collected and culture-maintained in HAM F12
(EuroClone, Wetherby, UK) supplemented with 0.166nM
retinoic acid (Sigma Chemical Co) and 5ml/500mL of
insulin-transforming selenium (ITS) medium (Becton Dick-
inson, NJ, USA), in 95% air/CO2 at 37
◦C. Upon 3
days of in vitro culture maintenance, SCs were incubated
with 10mM tris(hydroxymethyl)aminometane hydrochlo-
ride buﬀer (TRIS) (Sigma Chemical Co), as previously
reported in the literature, in order to eliminate the residual
germinal cells [21].
2.4. Encapsulation of Sertoli Cells within Alginate-Based
Microcapsules. SC were encapsulated in alginate-based
microcapsules according to our previously published meth-
ods [22–24]. Brieﬂy, conﬂuent SC monolayers (20 × 106
cells/T75 ﬂask) were scraped oﬀ the plate upon incubation
with 0.05% trypsin/ethylenediaminetetraacetic acid (EDTA)
(Gibco, Grandisland) (2 minutes), then washed, counted by
hemocytometer, and tested for viability. SCs were suspended
in1mLof1.8%aqueoussolutionofin-househighlypuriﬁed
sodium alginate (Na-AG) (Stern Italia, Milano, Italy). The
AG/SCsuspensionwascontinuouslyaspiratedbyaperistaltic
pump, at a ﬂow rate of 12–14mL/min, and extruded
through a mono-air-jet device (air ﬂow rate: 5l/min) under
sterile conditions. The alginate suspension was continuously
stirred to prevent cell clumping, which would possibly lead
to inhomogeneous SC distribution within microcapsules.
The formed microdroplets were collected on a BaCl2 bath
(1.2%, w/v) which immediately turned them into gel
microspheres, washed twice in saline, and employed upon
24 hours of in vitro culture maintenance. Before and after
microencapsulation, SC viability was assessed by staining the
preparations with ethidium bromide (EB) (Sigma Chemical
Co) and ﬂuorescein-diacetate (FDA) (Sigma Chemical Co),
under ﬂuorescence microscopy, as previously described
[18].
2.5. Insulin Secretory Patterns of NPI Monolayers. The
obtained NPI cell monolayers (originating from 30NPI/T25
ﬂask) were cocultured for 7, 14, 21 days with microen-
capsulated SC in Click’s medium (Sigma Chemical Co)
supplemented with 10% fetal bovine serum (EuroClone,
Wetherby, UK), 0.5% bovine serum albumin, fraction V
(BSA) (Sigma Chemical Co), 10mM nicotinamide (Sigma
ChemicalCo),2mML-glutamine(SigmaChemicalCo),and
penicillin +0.1mg/mL streptomycin (Sigma Chemical Co).
The study was repeated in triplicate. Media collected from
the ﬂasks, during culture maintenance, were centrifuged
at 300g for 5 minutes. The cell supernatants were stored
at −20
◦C before undergoing insulin assay by RIA (Myria,
Milano,Italy).Glucose-stimulatedinsulinrelease(GSIR)was
determined upon stepwise, 90 minutes, sequential exposure
of the tissue to 50mg/dL (2.66mM) −300mg/dL (16.7mM)
−50mg/dL (2.66mM) D-glucose at 37
◦C, in 95% air/CO2.
The total obtained insulin was then normalized by the total
cell number and/or insulin+ cell number. Total cell number
was determined by staining cell nuclei with crystal violet,
solubilizing the adsorbed dye into a solution of Triton X-
100 and assessing optical density with a spectrophotometer
[25]. Insulin+ cell number was determined by immuhocyto-
chemistry (see Section 2.6). In addition, the ratio of insulin
content to total cell protein content (μU/mg protein) of NPI
cell monolayers cultured alone or in the presence of ESC
was determined. Brieﬂy, whole cellular extracts, prepared for
western-blotting analysis (see Section 2.7), were employed
for insulin assay by RIA and for total protein determination
according to Bradford method [26]. Data are reported as
average of 3 independent experiments.
2.6. Immunocytochemistry. Control and ESC cocultured NPI
cell monolayers were deposited on glass coverslips, washed
withPBS,andﬁxedwith4%paraformaldehydeinDulbecco’s
phosphate buﬀer (PBS) (EuroClone, Wetherby, UK). Cells
were washed in PBS/1% BSA thrice, then incubated with
10% goat serum in PBS/1% BSA for 30 minutes to block
nonspeciﬁc IgG binding. Upon dilution in PBS/1% BSA
and transfer into glass coverslips, the speciﬁc primary
antibodies, namely, 1 : 200 rabbit anti-mouse/rat pan-
creatic and duodenal homeobox gene 1 protein (PDX-1)
(Chemicon International, Temecula, CA), 1 : 150 rabbit
antiglucotransporter-2 (Glut-2) (Chemicon International,
Temecula, Calif, USA), 1 : 200 guinea pig anti-human insulin
(Linco, St. Louis, Mo, USA), 1 : 50 monoclonal mouse anti-
human cytokeratin 7 (Ck7) (Dako Cytomation, Glostrup,
Denmark), 1 : 50 rabbit anti-human glucokinase (GK)
polyclonal antibodies (Santa Cruz Biotechnology Inc., Santa
Cruz, Calif, USA), and mouse anti-porcine c-kit (kind gift by
Dr. Dominguez, Madrid, Spain) were incubated overnight at
4◦C in a humidiﬁed chamber. The coverslips were washed
thrice with PBS/1%BSA for 5 minutes, then incubated
with secondary antibodies (AlexaFluor 488 goat anti-rabbit,
AlexaFluor 488 goat anti-mouse, working solution 1 : 500)
(Molecular Probes, Carlsbad, Calif, USA), (Cy3 donkey
anti-mouse, Cy3 donkey anti-rabbit working solution 1
: 500, Amersham International, Otelﬁngen, Switzerland),
(rabbit anti-guineapig TRITC working solution 1 : 320,
(Sigma Chemical Co). The coverslips were washed thrice
with PBS/1%BSA, then mounted and examined under
ﬂuorescence microscopy (Nikon Eclipse TE2000-U) at 492
± 15nm for AlexaFluor 488 and 552 ± 15nm for Cy3. The
image processing and percentage of immunopositive cells
(%) were determined, by using the software Nikon Eclipse
EZ C1, version 2.30, by two independent investigators. For
each experimental condition, 20 diﬀerent images, containing
at least 300 cells in total, were counted. In every image, all
the cells were counted and subdivided into diﬀerent groups
if labeled for green ﬂuorescence or red ﬂuorescence, or
both (yellow ﬂuorescence). The experiment was repeated in
triplicate.4 Stem Cells International
Table 1: Cell type markers analyzed by immunocytochemistry on NPI cell monolayers cultured alone or with ESC.
Name Abbreviation Cell localization Cell type marker
Stem cell factor receptor c-kit/SCFR transmembrane
hematopoietic
stem cell marker;
growth and
diﬀerentiation of
β-cell
sub-populations
marker
Cytokeratin 7 Ck7 cytoplasmatic ductal cell marker
Insulin Ins cytoplasmatic β-cell marker
Pancreatic and duodenal homeobox gene 1 protein PDX-1 Nuclear and cytoplasmatic β-cell marker
2.7. Western-Blotting Analysis. Taking into consideration
the important eﬀects of ESC on viability and functional
competence of NPI monolayers, the eﬀects of ESC on NPI
diﬀerentiation markers were investigated by immunohisto-
chemistry.
Various diﬀerentiation markers were examined (see
Table 1).
Whole cellular extracts were prepared as follows:
cells obtained from NPI monolayers were resuspended
in 100μLo f1 0 m MT R I Sb a s e( S i g m aC h e m i c a lC o )a t
pH 7.4, 150mM NaCl, 1mM EDTA, 1mM ethyleneglycol
Bis(aminoethylether)Tetraaceticacid(EGTA),1%v/vTriton
X-100 (Sigma Chemical Co), 0.5% (v/v) Nonidet P-40
(Sigma Chemical Co), 1M NaF (Sigma Chemical Co), 0.2M
NaO3V (Sigma Chemical Co), and 0.2M phenylmethanesul-
fonylﬂuoride (Sigma Chemical Co). The mixture was then
spun at 1000g (Mikro 200, Hettich zentrifugen, Tuttlingen,
Germany) for 10 minutes, the supernatant was collected and
thetotalproteincontentdeterminedbytheBradfordmethod
[26].Smallsamplealiquotswerestoredat −20
◦CforWestern
blotting analysis.
Cell extracts were fractioned by 4–12% sodium dodecyl
sulphate polyacrylamide gel electrophoresis (SDS-PAGE),
50μg protein/lane, blotted on nitrocellulose membrane
(Biorad, Hercules, Calif, USA), and incubated overnight
in buﬀer containing 10mM TRIS, 0.5M NaCl, 1% (v/v)
Tween 20 (Sigma Chemical Co), 1 : 1000 anti-PDX-1 Ab
(Chemicon International, Temecula, CA), 1 : 200 anti-
GK Ab (Santa Cruz Biotechnology Inc., Santa Cruz, Calif,
USA), 1 : 2500 anti-Glut-2 Ab (Chemicon International),
1 : 1000 anti-actin Ab (Sigma Chemical Co). The Ag-Ab
complex was then detected by incubating the membrane for
additional 60 minutes in buﬀer containing 1 : 5000 horse
radish peroxidase-conjugated anti-rabbit IgG secondary Ab
(Sigma Chemical Co). Speciﬁc bands were detected by ECL
(enhanced chemiluminescence).
2.8. RT-PCR. Total RNA was isolated from cells obtained
from NPI cell monolayers by Invisorb Spin-cell RNA
mini-kit (Invitek GmbH, Berlin, Germany). RT was per-
formed by Sprint Power Script PrePrimed SingleShots
kit (Clontech, Palo Alto, Calif, USA). Oligos sequences
used are listed as forward then reverse, 5  to 3 : β-actin
5 -ATGGTGGGTATGGGTCAGAA-3  and 5 -CTTCTC-
CATGTCGTCCCAGT-3  amplify a product of 123bp,
Nkx6.1 5 -AGGATCCATTTTGTTGGACA-3  and 5 -CGC-
CAAGTATTTCGTTTGTT-3  amplify a product of 111bp,
PDX-1 5 -AGAGCCCGAGGAGAACAAG-3  and 5 -GCG-
GCCTAGAGATGTATTTG-3  amplify a product of 100bp,
Glut-2 5 -CCGAGTTTTTCAGTCAAGGA-3  and 5 -AGT-
CCGCAATGTACTGGAAG-3  amplify a product of 109bp,
GK 5 -TAGAGCAGATCCTGGCAGAG-3  and 5 -GTA-
GGTGGGCAGCATCTTC-3  amplify a product of 99bp,
NeuroD/Beta2 5 -CCTGTGCACCCCTACTCTTA-3 and
5 -TGCAGGATAGTGCATGGTAA-3  amplify a product of
272bp, Insulin 5 -CTTCTTCTACACGCCCAAGG-3  and
5 -CGGCCTAGTTGCAGTAGTTC-3  amplify a product of
190bp, c-kit 5 -ACAAATCCATGCCCACACCCT-3  and
5 -TTAAGCCGTATGCAGTGGCCTC-3  amplify a product
of 293bp.
RT-PCR analyses were performed in the Mx3000P
Instruments (Stratagene, La Jolla, Calif, USA) in a total vol-
ume of 20μL reaction mixture, following the manufacturer’s
recommendations, using the Brilliant SYBR Green QPCR
M a s t e rM i x2 x( S t r a t a g e n e )a n d1 0μMo fe a c hp r i m e ru s i n g
the dissociation protocol. Negative controls contained water
instead of ﬁrst-strand cDNA. Each sample was normalized
on the basis of its housekeeping gene (β-actin). The relative
gene expression levels were normalized to a calibrator that
was selected as to be the control sample (untreated). Final
results, expressed as relative expression, were calculated by
MxPro software (Stratagene).
2.9. Statistical Analysis. All data were expressed as mean
±SD of three independent experiments. Statistical analysis
was conducted by ANOVA. P-v a l u e s< .05 were considered
signiﬁcant.
3. Results
3.1. Eﬀects of Encapsulated Sertoli Cells on NPI Cell Monolay-
ers: Morphology and Insulin Secretory Patterns. As reported
by Figures 1(a) and 1(d), NPI adhesion process started
at day 1 throughout complete adhesion, in 7–10 days.
No appreciable morphological diﬀerences were detectable
between NPI monolayers cultivated alone (data not shown)Stem Cells International 5
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Figure 1: (a)–(c) Photomicrographs of NPI after culture for 1 (a), 6 (b), and 10 (c) days on T25 tissue ﬂasks for adherent cell growth.
(d) Light ﬁeld (left) and ﬂuorescence (right) photomicrographs of Ba-AG microcapsules containing SC. Fluorescence micrographs were
obtained after staining with EB+FDA to assess SC viability. (e) Insulin secretory patterns of control NPI cell monolayers alone after 14 days
(open bars) or NPI cell monolayers, cocultivated with microencapsulated SC for 7 (gray bars), 14 (hatched bars), and 21 days (ﬁlled bars)
of culture. During static incubation, the cells were treated with the indicated concentrations of glucose. Data represent the average of 3
independent experiments; each insulin determination was performed in triplicate ±SD.
and those cocultivated with ESC throughout day 21. No
signiﬁcant diﬀerences have been observed between NPI cell
monolayer cocultivated and NPI cell monolayer alone (data
not shown). As shown by Figure 1(d), ESC cocultivated with
NPI monolayers exhibited excellent morphology and cell
organization, with the cell viability testing higher than 80%
at day 21.
ESCstronglyinﬂuencedinsulinsecretorypatternsofNPI
(Figure 1(e)). In fact, for the entire duration of the culture
p e r i o d( u pt o2 1d a y s )t h eN P Ic e l lm o n o l a y e r sc u l t i v a t e d
alone, showed only limited insulin secretion (<0.7μU/mg
protein), while control NPI showed a clear lack of insulin
response to glucose (at 50-300-50mg/dL). By sharp contrast,
NPIcocultivatedwithESCshowedprogressivelybetterGSIR.
At day 21, the cocultivated NPIs were fully responsive to
glucose, and most importantly, were highly responsive to
variations of the glucose levels (P<. 05). As reported by
Figures 2 and 3, the ratio insulin/total cell number and/or
insulin+ cell number decreased in NPI cell monolayers
c o c u l t i v a t e dw i t hE S Cu pt o2 1d a y sa sc o m p a r e dt oN P I
cell monolayers alone, possibly because the increased insulin
release reﬂects the presence of more insulin expressing cells
in the treated cell monolayers.
The ratio insulin content/mg total protein, being insulin
content indicative of the diﬀerentiation/maturation of the
NPI cell monolayers and total cell protein content indicative
of the quantity of tissue, showed signiﬁcant progressive
increase of the endogenous insulin synthesis in the NPI cell
monolayers cocultured with ESC up to 21 days as compared
to NPI cell monolayers cultured alone (Figure 8(c)).
3.2. Eﬀects of Encapsulated Sertoli Cells on NPI Cell Mono-
layers: Evaluation of Diﬀerentiation Markers by Immuno-
histochemistry. Diﬀerent samples of control (untreated)
N P Ic e l lm o n o l a y e r sa n dE S Cc o c u l t u r e dN P Iu n d e r w e n t
double immunostaining with diﬀerent couples of primary
antibodies, namely: Ck7/Insulin (Figure 4), PDX-1/Insulin
(Figure 5), PDX-1/c-kit (Figure 6), Insulin+/c-kit (Figure 7).
Immunophenotype of the primary isolated NPI was
similar to the NPI cell monolayer patterns at 7 days (data not
shown).6 Stem Cells International
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Figure 2: Ratio insulin/total cell number of control NPI cell monolayers alone (open bars), or NPI cell monolayers cocultivated with
microencapsulated SC (gray bars) for 7 (a), 14 (b), and 21 days (c). Data are shown as means ±SD from 3 samples.
Fluorescence micrographs reported in Table 2 showed
that (a) the percentage of cells positive for both Ck7 and
Insulin, an immature cell phenotype, which would likely
suggest ductal origin of the β-cells, (Figure 4) declined
progressively in the NPI cell monolayers cocultured with
ESC,ascomparedtountreatedNPIcellmonolayershowever,
diﬀerence was statistically signiﬁcant only for the 21 day-
treated NPI (P<. 050); (b) the percentage of NPI double
positive for PDX-1/insulin, a mature β-cell phenotype
(Figure 5),andinsulin/c-kit,acellphenotypeassociatedwith
functionally immature β-cell subpopulations, signiﬁcantly
raised in the treated NPI populations both at days 14 and
21 (P<. 050) (Figure 6), ﬁnally (c) the percentage of cells
positive for PDX-1/c-kit (Figure 7) raised for the cocultured
NPI, but only at day 21. The diﬀerence between untreated
NPI and ESC-treated NPI was statistically signiﬁcant (P<
.050).
3.3. Eﬀects of Encapsulated Sertoli Cells on NPI Cell Mono-
layers: Evaluation of Diﬀerentiation Markers by Western Blot
Analysis. To conﬁrm the data obtained by immunocyto-
chemistry, a new set of experiments was planned by the
complementary western blotting technique. The results of
these experiments are reported in Figure 8 where both pho-
tographs of the nitrocellulose membranes and the barplots
ofthedensitometricanalysisareexhibited.TheWesternblots
conﬁrmedstatisticallysigniﬁcantdiﬀerencesbetweencontrol
NPIandNPIcoculteredinthepresenceofESC.Inparticular,
cocultured NPI showed a statistically signiﬁcant increase ofStem Cells International 7
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Figure 3: Ratio insulin/insulin+ cell number of control NPI cell monolayers alone (open bars), or NPI cell monolayers cocultivated with
microencapsulated SC (gray bars) for 7 (a), 14 (b), and 21 days (c). Data are shown as means ±SD from 3 samples.
Table 2: Immunohistochemical analysis of diﬀerentiation markers of NPI monolayers cultured alone or in the presence of ESC.
Cells (days) Ck7+/Insulin+ (%) PDX-1+/Insulin+ (%) Insulin+/c-kit+ (%) PDX-1/c-kit+ (%)
C (7) 58.5 ± 1.4 14.8 ± 3.9 10.0 ± 1.7 13.1 ± 2.3
+ESC (7) 55.3 ± 5.5 14.3 ± 3.0 9.7 ± 4.0 14.3 ± 9.7
C (14) 50.0 ± 3.8 20.7 ± 3.1 14.0 ± 3.7 25.7 ± 10.0
+ESC (14) 40.2 ± 2.4 33.3 ± 5.1
∗ 26.0 ± 0.9
∗ 31.1 ± 13.5
C (21) 45.6 ± 4.7 29.5 ± 4.9 15.8 ± 2.9 45.1 ± 11.0
+ESC (21) 32.9 ± 4.1
∗ 74.8 ± 4.9
∗ 38.3 ± 5.2
∗ 71.8 ± 10.8
∗
C: Control untreated NPI monolayers.
+ESC: NPI monolayers cocultured in the presence of encapsulated Sertoli cells.
Data represent the percentage of positive cells and are given as means ±SD (n = 3).
∗P < .050.8 Stem Cells International
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Figure 4: Double ﬂuorescence immunolabeling (green signal: anti-CK-7 Mo-Ab; red signal anti-insulin polyclonal Ab) under confocal laser
microscopy of NPI cell monolayers cultivated for 7 (a), (d), 14 (b), (e), and 21 (c), (f) days, alone (a)–(c) or with SC (d)–(f). Bar =10μm.
the expression of PDX-1, Glucokinase (GK), and GLUT-2 as
compared to controls (P<. 050).
3.4. Eﬀects of Encapsulated Sertoli Cells on NPI Cell Mono-
layers: Assessment of Diﬀerentiation Markers by Real Time
PCR (qPCR). qPCR analysis, reported by Figure 9, showed
statistically signiﬁcant diﬀerences in the expression of a
number of genes between treated and untreated NPI. At
day 21, the cocultured NPI showed remarkable increase in
the expression of PDX-1, NKx6.1, Insulin, and c-kit genes
(P<. 050). At days 7 and 21, the cocultured NPI showed
statistically signiﬁcant diﬀerences for Neuro D and Glut-2 as
compared to controls (P<. 050), meanwhile only at day 7
statistically signiﬁcant diﬀerences for Glut-2 were observed
(P<. 050). For Gk, no statistical signiﬁcant diﬀerences were
shown (data not shown).Stem Cells International 9
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Figure 5: Double ﬂuorescence immunolabeling (green signal: anti-PDX-1 Ab; red signal anti-insulin Ab) under confocal laser microscopy
of NPI cell monolayers cultivated for 7 (a), (d), 14 (b), (e), and 21 (c), (f) days, alone (a)–(c) or with SC (d)–(f). Bar =10μm.
4. Discussion
The restricted availability of cadaveric human donor pan-
creata in conjunction with poor results of the Immune Tol-
erance Network (ITN) multicentric clinical trial on human
islet cell transplantation [3] has considerably downsized
the impact of human islet transplantation on the possible
cure of TIDM. Moreover, possible risks for malignancies in
patients with diabetes treated with human insulin or insulin
analogues have recently been reported [2]. For these reasons,
new sources of insulin-producing cells are actively being
sought [4, 5]. In this respect, we had previously shown that
SCs are able to induce either mitogenic activity of adult
rat islet-beta cells [27] or rapid and signiﬁcant maturation10 Stem Cells International
(a)
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Control NPI monolayers + SC NPI monolayers + SC
Figure 6: Double ﬂuorescence immunolabeling (green signal: anti-PDX-1 Ab; red signal anti-c-kit Ab) under confocal laser microscopy of
NPI cell monolayers cultivated for 7 (a), (d), 14 (b), (e), and 21 (c), (f) days, alone (a)–(c) or with SC (d)–(f). Bar =10μm.
and diﬀerentiation of freshly isolated NPI into functionally
competent β-cells [5].
Freshly isolated NPI cell populations are typically com-
prised of a minority of β-cells, a majority of CK7+ cells,
while the remainder cell population coexpresses both insulin
and epithelial cell markers. In fact, as reported by Trivedi
et al. [7] and Korbutt et al. [4], NPI may take 4–10
or more weeks to reach as suﬃcient, diﬀerentiated β-cell
mass as to enable reversal of hyperglycemia after TX in
diabetic rodents. After in vitro exposure to SC, double
ﬂuorescence immunolabeling clearly showed that epithelial
cells,stainedwithanti-CK7MoAb,initiallyrepresentingover
60% of the total cell population, turned into insulin-positive
cells (74% as compared with 6% control NPI). Such anStem Cells International 11
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Control NPI monolayers + SC NPI monolayers + SC
Figure 7: Double ﬂuorescence immunolabeling (green signal: anti-c-kit Ab; red signal anti-insulin Ab) under confocal laser microscopy of
NPI cell monolayers cultivated for 7 (a), (d), 14 (b), (e), and 21 (c), (f) days, alone (a)–(c) or with SC (d)–(f). Bar =10μm.
acceleration of the islet cell maturation process, induced by
9-day SC coculture, and substantiated by functional insulin
data, was observed [5]. This process is limited by the NPI
mass loss during the experimental procedure indeed. Hence,
starting from NPI, we were able to generate long-lasting
NPI cell monolayers, with no use of extracellular matrices
or cell engineering approaches [11]. In this respect, NPI cell
monolayers could serve as an experimental tool to assess
the eﬀects of several growth factors on β-cell molecular
pathways, possibly allowing to examine the islet cell lineage
commitments and to expand the starting cell material [11].
The achieved results showed, for the ﬁrst time, that
NPI cell monolayers were associated with c-kit+ cells in
accordance to previous reports in mice and rats [15, 16, 28].12 Stem Cells International
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Figure 8: (a) Western blot analysis of the indicated proteins from control NPI cell monolayers (C) or NPI cell monolayers cocultured with
ESC (+ESC) for the indicated time periods. (b) The relative intensities of PDX-1 (open bars), Glut-2 (hatched bars), and GK (ﬁlled bars)
levels,asdeterminedbybanddensitometricanalysis.Theratioofthebandintensitieswasexpressedasapercentage withrespecttountreated
control NPI cell monolayers. Data are shown as means ±SD from 3 samples. ∗Signiﬁcant diﬀerence between two groups at each time point
(P<. 05). (c) Ratio insulin content/mg total protein of control NPI cell monolayers alone (open bars), or NPI cell monolayers, cocultivated
with microencapsulated SC (gray bars), for 7, 14, and 21 days of culture. Data are shown as means ±SD from 3 samples.
Confocal microscopy examination showed c-kit+/PDX-1+
and c-kit+/insulin+ cells that might represent progenitors,
and possibily β cell precursors. In fact, during pancreatic
development, diﬀerentiated cells derive from the PDX-1+
ductal precursor cells: consequently, colocalization of c-
kit/PDX-1 could coincide with endocrine β cell precursors
here, at 21 days of coculture, when c-kit and PDX-1 tran-
scription factors are upregulated in a pancreatic neogenesis
model. NeuroD/β2a n dN K x 6 . 1p r o m o t e rm R N As h o w e d
that during cell coculture, the cells shifted toward a more
mature phenotype. Glut-2 mRNA tended to decline at
14 and 21 days of coculture, possibly indicating protein
deregulation. Unlike some authors [29] and according to
others [30], we have observed, in our cell monolayers, c-
kit and insulin colocalization by factor 3-4 at 21 days of
culture. WB densitometric analysis has revealed an increase
of phosphorylated PDX-1 in the treated (statistically signi-
ﬁcative at 21 days) as compared to the control monolayers. It
is known that PDX-1 regulates the insulin gene expression,
sinergistically with other factors belonging to the helix-
loop-helic basic protein family. The resulting heterodimeric
complex binds to the E2 element of the insulin promoter
[11]. This data has been conﬁrmed by qPCR indicating that
at 21 days there is an insulin mRNA active transcription
in conjunction with the highest insulin content/mg total
protein ratio. However, not all insulin positive cells wereStem Cells International 13
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Figure 9: qPCR analysis of the indicated genes from NPI cell monolayers cocultivated in the presence of ESC for the indicated time periods.
(a) PDX-1 (open bars), NeuroD (gray bars), Nkx6.1 (hatched bars), and c-kit (ﬁlled bars). (b) Insulin (open bars), Glut-2 (hatched bars),
and GK (ﬁlled bars). The reported results are expressed as a percentage out of untreated control NPI cell monolayers. Data are shown as
means ±SD from 3 samples.
also marked positively for c-kit [16] thereby suggesting that
these cells could embody a subset of endocrine precursor
cells.
One of the possible mechanisms of action could be
related to SCF secretion. SCs produce SCF or c-kit ligand
that binds to and activates the transmembrane tyrosine
kinase receptor c-kit. SCF/c-kit interaction plays a very
important role in the development, function, and survival
of rodent islets of Langerhans [14, 15]. SCF has been
shown to promote an increase of insulin output in fetal rat
islets [15]. Interestingly, coculture of our cell monolayers
with microencapsulated SC induced an increase in PDX-
1+/insulin+ and c-kit+/insulin+ cell percentage, according
to previous observations by the use of SCF [31] in either fetal
human [17]o rr a t[ 28] islet experimental settings. Likewise,
an increase in PDX-1 and c-kit mRNA also was observed.
We found a signiﬁcant increase of endogenous insulin
output, under glucose stimulation, from the NPI cell
monolayers that were cocultured with SC, as compared to
NPI cell monolayers alone. In fact, static incubation clearly
documented that ESC-treated cell monolayers responded
physiologically to glucose changes within 90 minutes, dif-
ferently from controls that did not undergo comparable
maturation patterns. The decreasing ratio insulin/total cell
number and/or insulin+ cell number in NPI cell monolayers
cocultivatedwithESC,upto21days,ascomparedtoNPIcell
monolayers alone, probably reﬂects the increase of insulin
expressing cells in the treated monolayers. Moreover, the
ratioinsulincontent/mgtotalproteinprogressivelyincreased
for the entire culture time period (up to 21 days) likely indi-
cating that ECS seem to promote maturation. ESC-derived
SCF could induce the diﬀerentiation of islet cell precursors
by diﬀerent mechanisms, including phosphatidylinositol-3-
kinase (PI3K9), the Janus family of protein tyrosine kinases,
the Src family members, and the Ras-Raf-mitogen-activated
protein (MAP) kinase. These pathways mediate several
cellular processes, including increased gene transcription,
proliferation, diﬀerentiation, survival, and metabolic home-
ostasis [32, 33].
In conclusion, our data seems to support the idea that
microencapsulated SC may accelerate the diﬀerentiation
of monolayered porcine cell cultures in the short term.
This eﬀect could be explained by the increase of SC-
induced PDX-1+/insulin+ and c-kit+/insulin+ cell mass.
Potential consequences of these observations, with respect
to diﬀerentiation of mature porcine β-cells as a possibile
xenogeneic cell source in diabetes, are implicit.
Acknowledgments
ThisworkwassupportedbytheConsorzioInteruniversitario
per i Trapianti D’Organo, Rome, Italy. Mouse anti-porcine
c-kit was a kind gift from Dr. Dominguez. The technical
assistanceofDr.M.C.AgliettiandDr.C.Proiettiisgratefully
acknowledged. The technical assistance of Giuliano Pannacci
and Paolo Serra (farm “Barilari,” Gubbio) is gratefully
acknowledged. F. Mancuso, M. Calvitti, and G. Luca equally
contributed to this work.
References
[1] D. M. Nathan, “The rationale for glucose control in diabetes
mellitus,” Endocrinology and Metabolism Clinics of North
America, vol. 21, no. 2, pp. 221–235, 1992.
[ 2 ]L .G .H e m k e n s ,U .G r o u v e n ,R .B e n d e r ,e ta l . ,“ R i s ko f
malignancies in patients with diabetes treated with human
insulin or insulin analogues: a cohort study,” Diabetologia, vol.
52, no. 9, pp. 1732–1744, 2009.14 Stem Cells International
[3] A. M. J. Shapiro, C. Ricordi, B. J. Hering, et al., “International
trial of the Edmonton protocol for islet transplantation,” The
New England Journal of Medicine, vol. 355, no. 13, pp. 1318–
1330, 2006.
[ 4 ]G .S .K o r b u t t ,J .F .E l l i o t t ,Z .A o ,D .K .S m i t h ,G .L .W a r n o c k ,
a n dR .V .R a j o t t e ,“ L a r g es c a l ei s o l a t i o n ,g r o w t h ,a n df u n c t i o n
of porcine neonatal islet cells,” Journal of Clinical Investigation,
vol. 97, no. 9, pp. 2119–2129, 1996.
[5] G. Luca, C. Nastruzzi, M. Calvitti, et al., “Accelerated func-
tional maturation of isolated neonatal porcine cell clusters: in
vitro and in vivo post-transplant results in NOD mice,” Cell
Tranplantation, vol. 14, pp. 249–261, 2005.
[6] K.Cardona,G.S.Korbutt,Z.Milas,etal.,“Long-termsurvival
of neonatal porcine islets in nonhuman primates by targeting
costimulation pathways,” Nature Medicine, vol. 12, no. 3, pp.
304–306, 2006.
[ 7 ]N .T r i v e d i ,J .H o l l i s t e r - L o c k ,M .D .L o p e z - A v a l o s ,e ta l . ,
“Increase in β-cell mass in transplanted porcine neonatal
pancreatic cell clusters is due to proliferation of β-cells and
diﬀerentiation of duct cells,” Endocrinology, vol. 142, no. 5, pp.
2115–2122, 2001.
[ 8 ]A .G .M u r r a y ,R .C .N e l s o n ,G .R .R a y a t ,J .F .E l l i o t t ,a n d
G. S. Korbutt, “Neonatal porcine islet cells induce human
CD4+,butnotCD8+,lymphocyteproliferationandresistcell-
mediated cytolytic injury in vitro,” Diabetes,v o l .4 8 ,n o .9 ,p p .
1713–1719, 1999.
[ 9 ]G .S .K o r b u t t ,G .L .W a r n o c k ,a n dR .V .R a j o t t e ,“ I s l e t
transplantation,” in Physiology and Pathophysiology of the Islets
of Langerhans, vol. 426 of Advances in Experimental Medicine
and Biology, pp. 397–410, Springer, New York, NY, USA, 1997.
[10] R. A. Vald´ es-Gonz´ alez, L. M. Dorantes, G. N. Garibay,
et al., “Xenotransplantation of porcine neonatal islets of
Langerhans and Sertoli cells: a 4-year study,” European Journal
of Endocrinology, vol. 153, no. 3, pp. 419–427, 2005.
[11] F. Mancuso, G. Basta, M. Calvitti, et al., “Long-term cultured
neonatalporcineisletcellmonolayers:apotentialtissuesource
for transplant in diabetes,” Xenotransplantation,v o l .1 3 ,n o .4 ,
pp. 289–298, 2006.
[12] K. Morrison-Graham and Y. Takahashi, “Steel factor and c-kit
receptor: from mutants to a growth factor system,” BioEssays,
vol. 15, no. 2, pp. 77–83, 1993.
[13] V. C. Broudy, “Stem cell factor and hematopoiesis,” Blood, vol.
90, no. 4, pp. 1345–1364, 1997.
[14] C. Oberg-Welsh, J. Waltenberger, L. Claesson-Welsh, and M.
Welsh, “Expression of protein tyrosine kinase in islet cells:
possible role of the Flk-1 receptor for β-cell maturation from
duct cells,” Growth Factors, vol. 10, pp. 115–126, 1994.
[15] C. Oberg-Welsh and M. Welsh, “Eﬀects of certain growth
factors on in vitro maturation of rat fetal islet-like structures,”
Pancreas, vol. 12, no. 4, pp. 334–339, 1996.
[16] L. Rachdi, L. El Ghazi, F. Bemex, J. J. Panthier, P. Czrnichow,
and R. Scharfmann, “Expression of the receptor tyrosine
kinase KIT in mature beta-cells and in the pancreas in
development,” Diabetes, vol. 50, pp. 2021–2028, 2001.
[ 1 7 ]J .L i ,K .L y t e ,F .F e l l o w s ,C .G .G o o d y e r ,a n dR .W a n g ,“ T h e
role of c-kit and its ligand stem cell factor in the development
human pancreas,” Diabetes, vol. 54, p. S39, 2005.
[18] M. Miyamoto, Y. Morimoto, Y. Nozawa, A. N. Balamurugan,
B. Xu, and K. Inoue, “Establishment of ﬂuorescein diacetate
and ethidium bromide (FDAEB) assay for quality assessment
of isolated islets,” Cell Transplantation, vol. 9, no. 5, pp. 681–
686, 2000.
[19] G. S. Korbutt, J. F. Elliott, and R. V. Rajotte, “Cotrans-
plantation of allogeneic islets with allogeneic testicular cell
aggregates allows long-term graft survival without systemic
immunosuppression,” Diabetes, vol. 46, no. 2, pp. 317–322,
1997.
[20] J. P. Mather and D. D. Philips, “Primary culture of testicular
somatic cells,” in Methods for Serum Free Culture of Cells of the
EndocrineSystem,D .W .Barnes,D .A.Sirbasku,andG.H.Sato ,
Eds., pp. 24–45, New York Liss, New York, NY, USA, 1999.
[21] M. Galdieri, E. Riparo, F. Palombi, M. A. Russo, and M. J.
Stefanini,“PureSertolicellcultures:anewmodelforthestudy
of somatic-germ cell interaction,” Journal of Andrology, vol. 2,
pp. 249–254, 1981.
[22] R. Calaﬁore and G. Basta, “Alginate/Poly-l-ornithine micro-
capsules for pancreatic islet cell immunoprotection,” in Cell
Encapsulation Technology and Therapeutics, W. Kuhtreiber, R.
P. Lanza, and W. L. Chick, Eds., pp. 138–150, Birkh¨ auser,
Boston, Mass, USA, 1999.
[23] R. Calaﬁore, “Alginate microcapsules for pancreatic islet cell
graft immunoprotection: struggle and progress towards the
ﬁnal cure for type 1 diabetes mellitus,” Expert Opinion on
Biological Therapy, vol. 3, no. 2, pp. 201–205, 2003.
[24] G. Luca, M. Calvitti, C. Nastruzzi, et al., “Encapsulation, in
vitro characterization and in vivo biocompatibility of sertoli’s
cells in alginate based microcapsules,” Tissue Engineering, vol.
13, pp. 641–648, 2007.
[25] R. J. Gillies, N. Didier, and M. Denton, “Determination of cell
number in monolayer cultures,” Analytical Biochemistry, vol.
159, no. 1, pp. 109–113, 1986.
[26] M. M. Bradford, “A rapid and sensitive method for the
quantitation of microgram quantities of protein utilizing the
principle of protein dye binding,” Analytical Biochemistry, vol.
72, no. 1-2, pp. 248–254, 1976.
[27] G. Luca, M. Calvitti, L. M. Neri, et al., “Sertoli cell-induced
reversal of adult rat pancreatic islet cells into fetal status:
potential implications for islet transplantation in type I
diabetesmellitus,”JournalofInvestigativeMedicine,vol.48,no.
6, pp. 441–448, 2000.
[28] N. K. Yashpal, J. Li, and R. Wang, “Characterization of
c-Kit and nestin expression during islet cell development
in the prenatal and postnatal rat pancreas,” Developmental
Dynamics, vol. 229, no. 4, pp. 813–825, 2004.
[29] K. Peters, R. Panienka, and J. Li, “Expression of stem cell
markers and transcription factor during the remodelling of
the rat pancreas after duct ligation,” Virchows Arch, vol. 446,
pp. 56–63, 2005.
[30] R. Wang, J. Li, and N. Yashpal, “Phenotypic analysis of c-Kit
expression in epithelial monolayers derived from postnatal rat
pancreatic islets,” Journal of Endocrinology, vol. 182, no. 1, pp.
113–122, 2004.
[31] J. Li, C. G. Goodyer, F. Fellows, and R. Wang, “Stem cell
factor/c-Kitinteractionsregulatehumanislet-epithelialcluster
proliferation and diﬀerentiation,” International Journal of
Biochemistry and Cell Biology, vol. 38, no. 5-6, pp. 961–972,
2006.
[ 3 2 ]T .J .H e m e s a t h ,E .R .P r i c e ,C .T a k e m o t o ,T .B a d a l i a n ,a n d
D. E. Fisher, “MAP kinase links the transcription factor
Microphthalmia to c-Kit signalling in melanocytes,” Nature,
vol. 391, no. 6664, pp. 298–301, 1998.
[33] T. B. Van Dijk, E. Van den Akker, M. Parren-Van Amelsvoort,
H. Mano, B. Lowenberg, and M. Von Lindern, “Stem
cell factor induces phosphatidylinositol 3 -kinase-dependent
Lyn/Tec/Dok-1 complex formation in hematopoietic cells,”
Blood, vol. 96, no. 10, pp. 3406–3413, 2000.Submit your manuscripts at
http://www.hindawi.com
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
 Anatomy 
Research International
Peptides
International Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation 
http://www.hindawi.com
 International Journal of
Volume 2014 Zoology
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Molecular Biology 
International 
Genomics
International Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
The Scientific 
World Journal
Hindawi Publishing Corporation 
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Bioinformatics
Advances in
Marine Biology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Signal Transduction
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
BioMed 
Research International
Evolutionary Biology
International Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Biochemistry 
Research International
Archaea
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Genetics 
Research International
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Advances in
Virology
Hindawi Publishing Corporation
http://www.hindawi.com
Nucleic Acids
Journal of
Volume 2014
Stem Cells
International
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Enzyme 
Research
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
International Journal of
Microbiology